从散装有效质量到二维航母机动性的准确预测,通过对抗性转移学习
Xinyu Chen1, Shuaihua Lu1, Qian Chen1
1Key Laboratory of Quantum Materials and Devices of Ministry of Education, School of Physics, Southeast University, Nanjing, China.
Nature communications
|June 25, 2024
概括
本研究引入了材料发现的混合框架,通过使用对抗性转移学习和专家知识来克服数据稀缺性,从批量数据中预测2D材料特性. 这种方法达到90%以上的准确性,使新型半导体的有效选成为可能.
科学领域:
- 材料科学 材料科学 材料科学
- 机器学习 机器学习
- 凝聚物质物理学 凝聚物质物理学
背景情况:
- 数据稀缺是用于材料发现的机器学习的一个主要挑战.
- 转移学习需要大数据集和小数据集之间有很强的相关性,这限制了其跨属性和跨材料应用.
研究的目的:
- 开发一种混合框架,以利用散装材料的知识来预测二维材料特性.
- 为了实现准确的预测,尽管数据稀缺和材料类型和性能差异.
主要方法:
- 开发了一个混合框架,将对抗转移学习和专家知识结合起来.
- 对抗性训练在散装和2D材料之间提取了共同的知识.
- 专家知识被纳入,以提高预测准确性和通用性.
主要成果:
- 仅使用晶体结构数据,可以预测2D材料的载体流动性,准确度超过90%.
- 确定了21个具有卓越载体移动性和合适带隙的2D半导体.
- 该框架证明了跨不同属性和材料的成功转移学习.
结论:
- 开发的混合框架有效地解决了材料发现中的数据稀缺问题.
- 这种方法可以在交叉属性和交叉材料场景中准确预测复杂的材料特性.
- 它为加速发现新型二维半导体材料提供了一个强大的工具.
相关概念视频
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...


